Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew Powell
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- North Shore-Lij Health System/center for Advanced Medicine
New Hyde Park, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- Carilion Clinic Gynecological Oncology
Roanoke, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Northwest Hospital
Seattle, Washington, United States
- Pacific Gynecology Specialists
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Swedish Medical Center-First Hill
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Green Bay Oncology Limited at Saint Mary'S Hospital
Green Bay, Wisconsin, United States
- Green Bay Oncology at Saint Vincent Hospital
Green Bay, Wisconsin, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
- Gundersen Lutheran Medical Center
La Crosse, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2009
- Primary completion
- 16 Jul 2016
- Completion
- 16 Jul 2016
- Last update posted
- 6 Dec 2017
- Registered enrollment
- 45
- Registry id
- NCT00888173
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.